Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXA2R | P21731 | 3/20 | 0.36 |
| ▸ | AR | P10275 | 1/20 | 0.34 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.31 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | ICAM1 | P05362 | 2/20 | 0.31 |
| ▸ | SELE | P16581 | 2/20 | 0.31 |
| ▸ | VCAM1 | P19320 | 2/20 | 0.31 |
| ▸ | ESRRA | P11474 | 1/20 | 0.31 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.31 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.31 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.31 |
| ▸ | SCN9A | Q15858 | 4/20 | 0.31 |
| ▸ | CCNC | P24863 | 1/20 | 0.30 |
| ▸ | CDK8 | P49336 | 1/20 | 0.30 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL275612 | 0.87 | TBXA2R (0.38) | TBXA2RARCYP11B1SLC6A4ICAM1 | |
| SCHEMBL278967 | 0.87 | TBXA2R (0.38) | TBXA2RARCYP11B1SLC6A4ICAM1 | |
| SCHEMBL279350 | 0.87 | TBXA2R (0.36) | TBXA2RARCYP11B1CYP11B2SLC6A4 | |
| SCHEMBL278919 | 0.87 | LMNA (0.40) | — | |
| SCHEMBL278922 | 0.81 | MAPT (0.32) | — | |
| SCHEMBL279335 | 0.81 | CA1 (0.36) | — | |
| SCHEMBL279098 | 0.79 | — | — | |
| SCHEMBL279114 | 0.76 | CCR5 (0.42) | ARSLC6A4PDE4APDE4BPDE4C | |
| SCHEMBL279179 | 0.76 | LMNA (0.44) | SLC6A4SCN9A | |
| SCHEMBL275677 | 0.76 | LMNA (0.44) | SLC6A4SCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8134001-B2 | Spiroindolinone derivatives | HOFFMANN-LA ROCHE INC. (US) | 2012-03-13 | — | — | US | disclosed |
| US-20090156610-A1 | Spiroindolinone Derivatives | DING QINGJIE | 2009-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156610-A1 | Spiroindolinone Derivatives | SDHA, AR, XPOT | TBXA2R 236/4885AR 2/4885CYP11B1 234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.